IRCT20230723058900N1招募中2 期
Investigating the effect of magnesium oxide supplementation on the quality of life of patients with cardiorenal syndrome caused by chronic heart failure with reduced ejection - A single-arm clinical trials
Rasht University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age over 18 years
- •Outpatients referred to the clinic diagnosed with chronic heart failure (ECO result with EF less than 40%)
- •Patients with renal failure or evidence of renal damage (decrease in GFR below normal for more than 3 months or albuminuria above 30 mg/dl in 24-hour urine)
- •GFR more than 30 mL/min
- •Serum magnesium below 2 mg/dl
排除标准
- •Current treatment with hemodialysis or peritoneal dialysis
- •Donated kidney recipient or kidney donor
- •Coronary artery bypass grafting
- •Previous parathyroidectomy
- •Hyperparathyroidism
- •Current treatment with medication or supplements containing magnesium (antacids)
- •Recent history of treatment with medicine or supplements containing magnesium
- •Any condition that interferes with the absorption of magnesium from the digestive system (short bowel syndrome / chronic pancreatitis)
- •Pregnant mothers, mothers during breastfeeding
- •Allergy to the contents of the medicine
- •Patient participation in other intervention trials
- •Hypothyroidism and hyperthyroidism
- •Patients showing features of other primary kidney diseases
- •Urinary tract infection
- •Any fever associated with infection
- •Active malignancies
- •Liver cirrhosis and chronic alcoholism
- •All people who used cigarettes and other tobacco products
- •ESRD and stage five CKD
- •Laxatives and other nephrotoxic drugs
研究者
相似试验
已完成
3 期
Effect of magnesium oxide supplementation on the gene expression associated with insulin, lipid and inflammatory metabolism in diabetic hemodialysis patientsHemodialysis.End stage renal diseaseN18.6IRCT20190912044757N1Islamic Azad University60
已完成
不适用
Evaluation of the effect of magnesium oxide on the pharmacokinetics of levodopa/carbidopahealthy male and femaleJPRN-UMIN000025222Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University10
已完成
不适用
The comparison of the effect of magnesium oxide and sodium valproate in migraine prophilaxis:Migrain headache.MigraineIRCT2015011716666N2Mazandaran University of Medical Sceinces80
已完成
2 期
The effect of Magnesium Oxide on Improvement of Carotid intima media Thickness in hemodialysis patientsEnd Stage Renal Disease.End stage renal diseaseIRCT138808202370N4Isfahan University of Medical Sciences54
招募中
2 期
Magnesium Oxide and Vitamin C in MigraineMigraine with auraMigraine without auraIRCT20201221049787N1Shahre-kord University of Medical Sciences82